CHAD SHEPHERD: Open Payments
NPI 1871626796 · LOCKPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,378 in 72 payments from 21 companies in 2025. Trend: 2023 $1,707 · 2024 $1,517 · 2025 $1,378
Food & beverage: $1,378
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $230 |
| Lilly USA, LLC | 14 | $200 |
| AstraZeneca Pharmaceuticals LP | 2 | $152 |
| SANOFI-AVENTIS U.S. LLC | 7 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| GlaxoSmithKline, LLC. | 4 | $62 |
| Edwards Lifesciences Corporation | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 3 | $46 |
| Insulet Corporation | 2 | $44 |
Products named: MOUNJARO, TZIELD, AIRSUPRA, Ozempic, Kerendia, REXULTI, Rybelsus, Omnipod.
Industry payments across NY — which companies pay providers there.
